Berton Zbar
#127,330
Most Influential Person Now
Berton Zbar's AcademicInfluence.com Rankings
Berton Zbarlaw Degrees
Law
#2320
World Rank
#2895
Historical Rank
Common Law
#82
World Rank
#90
Historical Rank
International Law
#455
World Rank
#570
Historical Rank
Berton Zbarbiology Degrees
Biology
#8148
World Rank
#11182
Historical Rank
Cell Biology
#311
World Rank
#319
Historical Rank
Genetics
#805
World Rank
#897
Historical Rank
Molecular Biology
#1004
World Rank
#1028
Historical Rank
Download Badge
Law Biology
Berton Zbar's Degrees
- PhD Molecular Biology Stanford University
Why Is Berton Zbar Influential?
(Suggest an Edit or Addition)Berton Zbar's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mutations of the VHL tumour suppressor gene in renal carcinoma (1994) (1721)
- Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma. (1994) (1630)
- Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas (1997) (1501)
- The Heidelberg classification of renal cell tumours (1997) (1125)
- HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. (2005) (889)
- Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dubé syndrome. (2002) (848)
- Loss of alleles of loci on the short arm of chromosome 3 in renal cell carcinoma (1988) (622)
- Mutations in the fumarate hydratase gene cause hereditary leiomyomatosis and renal cell cancer in families in North America. (2003) (559)
- Renal Tumors in the Birt-Hogg-Dubé Syndrome (2002) (553)
- Germline mutations in the von Hippel–Lindau disease tumor suppressor gene: Correlations with phenotype (1995) (532)
- Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors (2008) (520)
- Risk of renal and colonic neoplasms and spontaneous pneumothorax in the Birt-Hogg-Dubé syndrome. (2002) (503)
- Novel mutations of the MET proto-oncogene in papillary renal carcinomas (1999) (498)
- Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas. (1994) (484)
- von Hippel-Lindau disease: genetic, clinical, and imaging features. (1995) (481)
- Germline mutations in the Von Hippel‐Lindau disease (VHL) gene in families from North America, Europe, and Japan (1996) (478)
- Improved detection of germline mutations in the von Hippel‐Lindau disease tumor suppressor gene (1998) (453)
- Folliculin encoded by the BHD gene interacts with a binding protein, FNIP1, and AMPK, and is involved in AMPK and mTOR signaling (2006) (443)
- Activating mutations for the met tyrosine kinase receptor in human cancer. (1997) (441)
- Identification of intragenic mutations in the von Hippel-Lindau disease tumour suppressor gene and correlation with disease phenotype. (1994) (383)
- Birt-Hogg-Dubé syndrome: a novel marker of kidney neoplasia. (1999) (377)
- Germline BHD-mutation spectrum and phenotype analysis of a large cohort of families with Birt-Hogg-Dubé syndrome. (2005) (371)
- Genetic Basis of Cancer of the Kidney (2004) (367)
- Immunotherapy of cancer: regression of intradermal tumors and prevention of growth of lymph node metastases after intralesional injection of living Mycobacterium bovis. (1972) (361)
- Birt-Hogg-Dubé syndrome, a genodermatosis associated with spontaneous pneumothorax and kidney neoplasia, maps to chromosome 17p11.2. (2001) (346)
- A novel germ line juxtamembrane Met mutation in human gastric cancer (2000) (340)
- The candidate tumor suppressor gene, RASSF1A, from human chromosome 3p21.3 is involved in kidney tumorigenesis (2001) (336)
- Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. (1995) (328)
- Suppression of tumor growth at the site of infection with living Bacillus Calmette-Guérin. (1971) (306)
- Lung cysts, spontaneous pneumothorax, and genetic associations in 89 families with Birt-Hogg-Dubé syndrome. (2007) (303)
- Dysregulation of Met receptor tyrosine kinase activity in invasive tumors. (2002) (297)
- Trisomy 7-harbouring non-random duplication of the mutant MET allele in hereditary papillary renal carcinomas (1998) (295)
- Hereditary papillary renal cell carcinoma. (1994) (274)
- Evaluation and management of renal tumors in the Birt-Hogg-Dubé syndrome. (2005) (269)
- Novel mutations in FH and expansion of the spectrum of phenotypes expressed in families with hereditary leiomyomatosis and renal cell cancer (2005) (264)
- Somatic mutations in the kinase domain of the Met/hepatocyte growth factor receptor gene in childhood hepatocellular carcinomas. (1999) (260)
- BCG and cancer (first of two parts). (2010) (259)
- Hereditary leiomyomatosis and renal cell cancer: a syndrome associated with an aggressive form of inherited renal cancer. (2007) (239)
- Clinical and genetic characterization of pheochromocytoma in von Hippel-Lindau families: comparison with sporadic pheochromocytoma gives insight into natural history of pheochromocytoma. (1999) (238)
- Hereditary and sporadic papillary renal carcinomas with c-met mutations share a distinct morphological phenotype. (1999) (238)
- Kidney-targeted Birt-Hogg-Dube gene inactivation in a mouse model: Erk1/2 and Akt-mTOR activation, cell hyperproliferation, and polycystic kidneys. (2008) (235)
- Hereditary renal cancers. (2003) (231)
- High frequency of somatic frameshift BHD gene mutations in Birt-Hogg-Dubé-associated renal tumors. (2005) (229)
- Immunotherapy of Cancer: Regression of Tumors after Intralesional Injection of Living Mycobacterium bovis (1971) (227)
- Biologically active components from mycobacterial cell walls. I. Isolation and composition of cell wall skeleton and component P3. (1974) (221)
- Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease. (1997) (221)
- BCG and cancer. (1974) (212)
- Succinate dehydrogenase kidney cancer: an aggressive example of the Warburg effect in cancer. (2012) (206)
- Two North American families with hereditary papillary renal carcinoma and identical novel mutations in the MET proto-oncogene. (1998) (202)
- Hereditary papillary renal cell carcinoma: clinical studies in 10 families. (1995) (178)
- A mutation in the canine BHD gene is associated with hereditary multifocal renal cystadenocarcinoma and nodular dermatofibrosis in the German Shepherd dog. (2003) (177)
- Molecular analysis of genetic changes in the origin and development of renal cell carcinoma. (1991) (176)
- Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. (1995) (175)
- Tumor cytotoxicity in vitro by macrophages from mice infected with mycobacterium bovis strain BCG. (1974) (172)
- The genetic basis of cancer of the kidney. (2006) (170)
- Central nervous system involvement in Von Hippel‐Lindau disease (1991) (165)
- Construction of a 600-kilobase cosmid clone contig and generation of a transcriptional map surrounding the lung cancer tumor suppressor gene (TSG) locus on human chromosome 3p21.3: progress toward the isolation of a lung cancer TSG. (1996) (163)
- Mosaicism in von Hippel-Lindau disease: lessons from kindreds with germline mutations identified in offspring with mosaic parents. (2000) (162)
- Distinct hypermethylation patterns occur at altered chromosome loci in human lung and colon cancer. (1992) (161)
- Cellular proteins that bind the von Hippel-Lindau disease gene product: mapping of binding domains and the effect of missense mutations. (1995) (155)
- Identification of the Genes for Kidney Cancer: Opportunity for Disease-Specific Targeted Therapeutics (2007) (153)
- Oncogenic Mutants of RON and MET Receptor Tyrosine Kinases Cause Activation of the β-Catenin Pathway (2001) (152)
- Loss of heterozygosity and somatic mutations of the VHL tumor suppressor gene in sporadic cerebellar hemangioblastomas. (1998) (151)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. I. Tumor growth and metastasis. (1972) (148)
- Expression of Birt–Hogg–Dubé gene mRNA in normal and neoplastic human tissues (2004) (148)
- Re: Hereditary papillary renal cell carcinoma: clinical studies in 10 families. (1996) (143)
- Histopathology and molecular genetics of multiple cysts and microcystic (serous) adenomas of the pancreas in von Hippel-Lindau patients. (2000) (143)
- Characterization of the renal pathology of a familial form of renal cell carcinoma associated with von Hippel-Lindau disease: clinical and molecular genetic implications. (1995) (138)
- The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. (1992) (137)
- Familial renal oncocytoma: clinicopathological study of 5 families. (1998) (134)
- Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma. (1996) (133)
- Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. (1995) (129)
- Biologically active components from mycobacterial cell walls. II. Suppression and regression of strain-2 guinea pig hepatoma. (1974) (128)
- Focus on kidney cancer. (2004) (127)
- Genetic changes in human adrenocortical carcinomas. (1989) (125)
- Hepatic vascular tumors, angiectasis in multiple organs, and impaired spermatogenesis in mice with conditional inactivation of the VHL gene. (2003) (120)
- Suppression of murine tumor growth by immune reaction to the Bacillus Calmette-Guérin strain of Mycobacterium bovis. (1972) (118)
- Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene. (1995) (117)
- Early onset hereditary papillary renal carcinoma: germline missense mutations in the tyrosine kinase domain of the met proto-oncogene. (2004) (115)
- Clinical and genetic analysis of patients with pancreatic neuroendocrine tumors associated with von Hippel-Lindau disease. (2000) (111)
- Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect (1995) (111)
- Synthetic peptides define critical contacts between elongin C, elongin B, and the von Hippel-Lindau protein. (1999) (106)
- Renal cysts, renal cancer and von Hippel-Lindau disease. (1997) (105)
- Molecular analysis of the von Hippel-Lindau disease tumor suppressor gene in human lung cancer cell lines. (1994) (103)
- Immunotherapy of guinea pig cancer with bcg (1974) (102)
- Molecular and cellular characterization of human renal cell carcinoma cell lines. (1992) (101)
- Molecular genetic investigations of the mechanism of tumourigenesis in von Hippel-Lindau disease: analysis of allele loss in VHL tumours (2004) (100)
- Molecular mapping of deletion sites in the short arm of chromosome 3 in human lung cancer (1990) (100)
- Mutations in the VHL tumor suppressor gene and associated lesions in families with von Hippel-Lindau disease from central Europe (1996) (98)
- Prevalence of microscopic tumors in normal appearing renal parenchyma of patients with hereditary papillary renal cancer. (2000) (93)
- Genetics of renal-cell carcinoma and evidence for a critical role for von Hippel-Lindau in renal tumorigenesis. (1995) (91)
- A germ-line insertion in the Birt–Hogg–Dubé (BHD) gene gives rise to the Nihon rat model of inherited renal cancer (2004) (88)
- Tumor-graft rejection in syngeneic guinea pigs: evidence for a two-step mechanism. (1970) (87)
- Three tetranucleotide polymorphisms for loci: D3S1352; D3S1358; D3S1359. (1993) (86)
- Tumor-specific vaccine containing Mycobacterium bovis and tumor cells: safety and efficacy. (1972) (81)
- Solid renal tumor severity in von Hippel Lindau disease is related to germline deletion length and location (2004) (80)
- Antigenic specificity of hepatomas induced in strain-2 guinea pigs by diethylnitrosamine. (1969) (77)
- Clinical and Genetic Studies of Renal Cell Carcinomas in a Family with a Constitutional Chromosome 3; 8 Translocation: Genetics of Familial Renal Carcinoma (1993) (76)
- Immunotherapy of cancer: regression of established intradermal tumors after intralesional injection of mycobacterial cell walls attached to oil droplets. (1974) (75)
- Mapping of the von Hippel-Lindau disease locus to a small region of chromosome 3p by genetic linkage analysis. (1991) (75)
- Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. (1995) (75)
- Detailed mapping of germline deletions of the von Hippel-Lindau disease tumour suppressor gene. (1994) (74)
- Third International Meeting on von Hippel-Lindau disease. (1999) (72)
- Tumor suppression by cell walls of mycobacterium bovis attached to oil droplets. (1972) (72)
- Protective Function of von Hippel-Lindau Protein against Impaired Protein Processing in Renal Carcinoma Cells (1999) (69)
- Regression of established intradermal tumors and lymph node metastases in guinea pigs after systemic transfer of immune lymphoid cells. (1977) (68)
- Studying cancer families to identify kidney cancer genes. (2003) (67)
- A transforming ras gene in tumorigenic guinea pig cell lines initiated by diverse chemical carcinogens. (1984) (67)
- Endolymphatic Sac Tumors: A Source of Morbid Hearing Loss in von Hippel-Lindau Disease (1997) (67)
- Genotype-phenotype correlation in von Hippel-Lindau disease: identification of a mutation associated with VHL type 2A. (1996) (67)
- Imaging features of hereditary papillary renal cancers. (1997) (63)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis., 2. Comparative effects of vaccinia virus, oxazolone, and turpentine. (1972) (61)
- Retention of chromosome 3 in extrapulmonary small cell cancer shown by molecular and cytogenetic studies. (1989) (61)
- Tumor-Specific Antigens Detected by Inhibition of Macrophage Migration (1969) (61)
- Inherited carcinomas of the kidney. (1998) (60)
- Somatic Alterations Contributing to Metastasis of a Castration‐Resistant Prostate Cancer (2013) (59)
- Familial pheochromocytoma associated with a novel mutation in the von Hippel-Lindau gene. (1996) (59)
- Acquired cellular immunity: extracellular killing of Listeria monocytogenes by a product of immunologically activated macrophages. (1974) (58)
- Mapping the Von Hippel-Lindau disease tumour suppressor gene: identification of germline deletions by pulsed field gel electrophoresis. (1993) (58)
- The Drosophila homolog of the human tumor suppressor gene BHD interacts with the JAK-STAT and Dpp signaling pathways in regulating male germline stem cell maintenance (2006) (58)
- Von Hippel-Lindau disease and sporadic renal cell carcinoma. (1995) (56)
- Constitutional von Hippel-Lindau (VHL) gene deletions detected in VHL families by fluorescence in situ hybridization. (1999) (56)
- Tumor hnmunity: Tumor Suppression in vivo Initiated by Soluble Products of Specifically Stimulated Lymphocytes (1971) (56)
- Somatic von Hippel-Lindau mutation in clear cell papillary cystadenoma of the epididymis. (1995) (55)
- An important von Hippel-Lindau tumor suppressor domain mediates Sp1-binding and self-association. (1999) (54)
- Gene structure of the human MET proto-oncogene (1997) (54)
- Clonality of pulmonary metastases from the bladder 6 subline of the B16 melanoma studied by southern hybridization. (1987) (54)
- Renal cell carcinoma of end-stage renal disease: a histopathologic and molecular genetic study. (1996) (53)
- Impaired inflammatory response in tumor-bearing guinea pigs. (1972) (53)
- Histopathology of Tumor Regression After Intralesional Injection of Mycobacferium bovis. IV. Development of Immunity to Tumor Cells and BCG (1973) (53)
- Fumarate hydratase enzyme activity in lymphoblastoid cells and fibroblasts of individuals in families with hereditary leiomyomatosis and renal cell cancer (2006) (52)
- Transplantable hepatomas induced in strain-2 guinea pigs by diethylnitrosamine: characterization by histology, growth, and chromosomes. (1969) (51)
- Expression of the Von Hippel-Lindau Tumor Suppressor Gene, VHL, in Human Fetal Kidney and During Mouse Embryogenesis (1995) (49)
- Loss of heterozygosity on the short arm of chromosome 3 in sporadic, von hippel‐lindau disease‐associated, and familial pheochromocytoma (1995) (49)
- Chromosome imbalances in papillary renal cell carcinoma and first cytogenetic data of familial cases analyzed by comparative genomic hybridization. (1996) (46)
- Molecular genetic characterization of neuroendocrine lung cancer cell lines. (1995) (45)
- Subcellular localization of the von Hippel‐Lindau disease gene product is cell cycle‐dependent (1998) (43)
- Mechanism of tumorigenesis of renal carcinomas associated with the constitutional chromosome 3;8 translocation. (1995) (43)
- Tumor suppression by pyran copolymer: correlation with production of cytotoxic macrophages. (1975) (43)
- Disruption of a novel MFS transporter gene, DIRC2, by a familial renal cell carcinoma-associated t(2;3)(q35;q21). (2002) (42)
- Clinical and molecular analyses of deletion 3p25-pter syndrome. (1993) (42)
- Two-step mechanism of tumor graft rejection in syngeneic guinea pigs. II. Initiation of reaction by a cell fraction containing lymphocytes and neutrophils. (1970) (42)
- Expression of von Hippel–Lindau Protein in Normal and Pathological Human Tissues (1999) (40)
- Loss of heterozygosity at the c-raf locus in small cell lung carcinoma. (1989) (40)
- Effects of Different Fixatives on β-Galactosidase Activity (2002) (40)
- Tumor regression mediated by Mycobacterium bovis (strain BCG). Effects of isonicotinic acid hydrazide, cortisone acetate, and antithymocyte serum. (1973) (38)
- Tumor regression mediated by Mycobacterium bovis (strain BCG). (1972) (38)
- The genetic basis of cancer of kidney cancer: implications for gene‐specific clinical management (2005) (38)
- Detection of von Hippel-Lindau disease gene mutations in paraffin-embedded sporadic renal cell carcinoma specimens. (1996) (38)
- Isolation and characterization of the full-length 3′ untranslated region of the human von Hippel-Lindau tumor suppressor gene (1996) (37)
- Clinical research priorities in Renal cell carcinoma (1997) (37)
- An experimental model for immunotherapy of cancer. (1973) (35)
- Mycobacterial cell wall components in tumor suppression and regression. (1973) (35)
- Regression of established tumors and induction of tumor immunity by intratumor chemotherapy. (1976) (35)
- Loss of heterozygosity on the short arm of chromosome 3 in mesothelioma cell lines and solid tumors (1994) (34)
- Systemic transfer of tumor immunity: delayed hypersensitivity and suppression of tumor growth. (1970) (33)
- Familial renal carcinoma: clinical evaluation, clinical subtypes and risk of renal carcinoma development. (2007) (33)
- Involvement of the RAFI locus, at band 3p25, in the 3p deletion of small‐cell lung cancer (1991) (33)
- Bystander suppression of tumor growth: evidence that specific targets and bystanders are damaged by injury to a common microvasculature. (1982) (32)
- Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG. (1974) (31)
- Tumorigenesis mediated by MET mutant M1268T is inhibited by dominant-negative Src (2000) (30)
- Inhibition of murine sarcoma virus oncogenesis with living BCG (1971) (29)
- Tumor-specific, cell-mediated immunity in guinea pigs with tumors. (1973) (29)
- The human homolog of the rodent immediate early response genes, PC4 and TIS7, resides in the lung cancer tumor suppressor gene region on chromosome 3p21 (1997) (28)
- Von Hippel-Lindau (VHL) disease: distinct phenotypes suggest more than one mutant allele at the VHL locus (1991) (28)
- Antitumor activity of bacterial infection. I. Effect of Listeria monocytogenes on growth of a murine fibrosarcoma. (1975) (27)
- Eradication of microscopic lymph nodes metastases after injection of living BCG adjacent to the primary tumor. (1975) (27)
- Molecular genetic studies of sporadic and familial renal cell carcinoma. (1993) (26)
- Chromosomal deletions in lung cancer and renal cancer. (1989) (26)
- Vascular defects and liver damage by the acute inactivation of the VHL gene during mouse embryogenesis (2006) (26)
- Serologic surveys of human cancer patients for antibody to adenovirus T antigens. (1970) (25)
- Molecular analysis of the short arm of chromosome 3 in five renal oncocytomas. (1990) (24)
- Immunologic approaches to various types of cancer with the use of BCG and purified protein derivatives. (1973) (24)
- Immunotherapy of Cancer: An Experimental Model in Syngeneic Guinea Pigs (1970) (24)
- Immunotherapy of an intramuscular tumor in strain-2 guinea pigs: prevention of tumor growth by intradermal immunization and by systemic transfer of tumor immunity. (1970) (22)
- Detection of cellular immunity to tumor antigens of a guinea pig hepatoma by inhibition of macrophage migration. (1972) (21)
- Effects of different fixatives on beta-galactosidase activity. (2002) (21)
- Transfer of tumor-specific delayed hypersensitivity in vitro to normal guinea pig peritoneal exudate cells using RNA extracts from sensitized lymphoid tissues. (1973) (21)
- Improved detection of allele loss in renal cell carcinomas after removal of leukocytes by immunologic selection. (1989) (21)
- Specific inhibition of tumor cell DNA synthesis in vitro by lymphocytes from peritoneal exudate of immunized syngeneic guinea pigs. (1970) (20)
- Antitumor activity of bacterial infection. II. effect of Listeria monocytogenes on growth of a guinea pig hepatoma. (1975) (19)
- Adjuvants for a tumor-specific vaccine: Bordetella pertussis or mycobacterial cell walls attached to oil droplets. (1973) (19)
- Eradication by immunization with mycobacterial vaccines and tumor cells of microscopic metastases remaining after surgery. (1979) (19)
- Mechanisms of immunological eradication of a syngeneic guinea pig tumor: participation of a component(s) of recipient origin in the expression of systemic adoptive immunity. (1983) (19)
- Von Hippel-Lindau disease: identification of deletion mutations by pulsed-field gel electrophoresis (1993) (19)
- Genetic basis of renal cell cancer. (1993) (18)
- Suppression of tumor growth and regression of established tumor with oil-attached mycobacterial fractions. (1974) (17)
- H255Y and K508R missense mutations in tumour suppressor folliculin (FLCN) promote kidney cell proliferation (2016) (17)
- Inherited epithelial tumors of the kidney: old and new diseases. (2000) (17)
- Abrogation of passively transferred tumor immunity in vivo by antigenically related tumor cells. (1971) (17)
- Familial pheochromocytoma due to mutant von Hippel-Lindau disease gene. (1997) (15)
- Guinea pig leukemia L2C: characterization of chromosomes and attempts to demonstrate antigenicity. (1970) (15)
- In Reply: Prevalence of Microscopic Lesions in Grossly Normal Renal Parenchyma From Patients with von Hippel-Lindau Disease, Sporadic Renal Cell Carcinoma and No Renal Disease (1995) (15)
- Failure of cryosurgical treatment of experimental intradermal tumors to eradicate microscopic lymph node metastases in guinea pigs. (1979) (14)
- Adjuvant-antigen requirements for active specific immunotherapy of microscopic metastases remaining after surgery. (1980) (14)
- Immunologic approaches to the treatment of human cancer based on a guinea pig model (1976) (13)
- Three polymorphic dinucleotide repeats near the von Hippel Lindau (VHL) disease gene on human chromosome 3: D3S587; D3S1317; D3S1435. (1993) (13)
- Isolation and regional localization of a large collection (2,000) of single-copy DNA fragments on human chromosome 3 for mapping and cloning tumor suppressor genes (1991) (12)
- Randomized clinical study on intratumoral BCG-cell wall preparation (CWP) therapy in patients with squamous cell carcinoma in the head and neck region (1981) (12)
- Glucan: attempts to demonstrate therapeutic activity against five syngeneic tumors in guinea pigs and mice. (1978) (12)
- Histopathology of Mycobacterium bovis (BCG)-mediated tumor regression. (1972) (12)
- Suppression and regression of a transplanted tumor in the guinea pig colon mediated by Mycobacterium bovis, strain BCG. (1975) (12)
- Plasma therapy of primary rat mammary carcinoma: antitumor activity of tumor-bearer plasma adsorbed against inactivated CNBr sepharose or protein A-sepharose. (1984) (11)
- Immunotherapy of bilateral lymph node metastases in guinea pigs by intralesional or paralesional injection of Mycobacterium bovis (BCG). (1978) (11)
- Tumor immunity: impairment in tumor-bearing hosts. (1971) (11)
- Tumor cells transfected with the neomycin resistance gene (neo) contain unique genetic markers useful for identification of tumor recurrence and metastasis. (1987) (11)
- Facial papules, spontaneous pneumothorax, and renal tumors. (2003) (11)
- Histologic and ultrastructural studies of tumor regression in inbred guinea pigs after intralesional injection of Mycobacterium bovis (BCG). (1973) (11)
- Local antitumor activity of a primary and an anamnestic response to a syngeneic guinea pig hepatoma. (1975) (11)
- Hereditary papillary renal carcinoma: pathology and pathogenesis. (1999) (10)
- Immunotherapy of a guinea pig hepatoma with ultrasonically prepared mycobacterial vaccines (1977) (10)
- TaqI and PstI RFLPs in the von Hippel-Lindau disease gene (VHL). (1993) (10)
- Eradication by active specific immunotherapy of established tumor transplants and microscopic lymph node metastases. (1982) (9)
- Destruction of syngeneic tumors by tuberculin-stimulated peritoneal exudate cells from guinea pigs immunized to Mycobacterium bovis (strain BCG). (1974) (9)
- The use of molecular genetic analysis in the diagnosis of renal cell carcinoma (2004) (9)
- Renal cell carcinoma. Molecular genetics and clinical implications. (1995) (9)
- Localization of a novel natural killer triggering receptor locus to human chromosome 3p23-p21 and mouse chromosome 9. (1993) (8)
- Six dinucleotide microsatellite polymorphisms on human chromosome 3. (1993) (8)
- Plasma therapy of primary rat mammary carcinoma: dependence of consumption of C3 during absorption of plasma with sepharose derivatives on the anticoagulant. (1985) (8)
- Safety and efficacy of living BCG or BCG cell walls (CW) in the treatment of a guinea pig hepatoma (1979) (8)
- PREVALENCE OF MICROSCOPIC LESIONS IN GROSSLY NORMAL DISEASE, SPORADIC RENAL CELL CARCINOMA AND NO RENAL DISEASE: CLINICAL IMPLICATIONS RENAL PARENCHYMA FROM PATIENTS WITH VON HIPPEL-LINDAU (2010) (7)
- A novel donor splice site mutation associated with two mRNAs in von Hippel-Lindau disease. (1994) (7)
- Treatment by limited surgery and specific immunization of guinea pigs with stage II experimental cancer (1981) (7)
- Special Notice to Contributors (1996) (7)
- Tumor rejection mediated by an amphotropic murine leukemia virus. (1983) (6)
- Three tetrameric repeat polymorphisms on human chromosome 3: D3S1349; D3S1350; D3S1351. (1993) (6)
- Immunoprophylaxis of Syngeneic Methylcholanthrene-induced Murine Sarcomas with Bacillus Calmette-Guérin and Tumor Cells (1980) (6)
- In vivo immunologic selection of proviral gene deletion variants from a nonproducer clone. (1986) (5)
- Rejection of retrovirus-infected tumor cells in guinea pigs: effect on bystander tumor cells. (1983) (5)
- Immunotherapy of experimental cancer with BCG and surgery (1975) (5)
- Antigenic variants isolated from a mutagen-treated guinea pig fibrosarcoma. (1984) (5)
- 980: Analysis of 3-CM Tumor Size Threshold for Intervention in Patients with Birt-Hogg-Dubé and Hereditary Papillary Renal Cancer (2005) (5)
- Physical mapping of chromosome 3p25-p26 by flourescence in situ hybridisation (FISH) (1993) (5)
- Clinical and genetic analysis of patients with pancreatic neuroendocrine tumours associated with von Hippel‐Lindau disease (2000) (5)
- A new polymorphic probe on chromosome 3p: ?LIB38-96 (D3S191) (1990) (5)
- Intracolonic injection of BCG in the rhesus monkey. (1974) (4)
- Comprehensive characterization of Alu‐mediated breakpoints in germline VHL gene deletions and rearrangements in patients from 71 VHL families (2021) (4)
- Monogenetic hypertension and pheochromocytoma. (1996) (4)
- Immunotherapy of a guinea pig hepatoma with living BCG. A frozen liquid and a lyophilized preparation are equally active (1977) (4)
- Prevention of tumor growth after intradermal injection of BCG extracts: a comparison of results in strain-2 guinea pigs from the National Institutes of Health and from the National Jewish Hospital and Research Center. (1976) (4)
- Regression of established oral tumors after intralesional injection of living BCG OR BCG cell walls (1979) (4)
- Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens. (1981) (4)
- A new polymorphic probe on chromosome 3p: lambda LIB28-77 (D3S169E) (1990) (4)
- Brief Communication: Intracolonlc Injection of BeG in the Rhesus Monkey (1974) (4)
- Original Articles: Kidney Cancer (1995) (3)
- Detection of germline mutations in the von Hippel-Lindau disease gene by the primer specified restriction map modification method. (1995) (3)
- Serotherapy of primary rat mammary carcinoma: inhibition by ethylenedinitrilotetraacetic acid but not by [ethylenebis(oxyethylenenitrilo)]tetraacetic acid. (1986) (3)
- Immunotherapy of guinea pig cancer with BCG. (1974) (3)
- CLINICAL AND GENETIC CHARACTERIZATION OF COMPARISON WITH SPORADIC PHEOCHROMOCYTOMA GIVES INSIGHT INTO NATURAL HISTORY OF PHEOCHROMOCYTOMA PHEOCHROMOCYTOMA IN VON HIPPEL-LINDAU FAMILIES: (1999) (2)
- A reliable method for reconstituting thymectomized, lethally irradiated guinea pigs with bone marrow cells. (1984) (2)
- A new polymorphic probe on chromosome 3p: λLIB33–29′ (D3S629) (1991) (2)
- A new polymorphic probe on chromosome 3p: λLIB09–75′ (D3S584) (1991) (2)
- Loss of DNA sequences on chromosome 3 in renal cell carcinoma. (1987) (2)
- Genetic techniques in the diagnosis of carcinomas of the kidney. (1995) (2)
- Selection and rejection of retrovirus-expressing tumor cells from a heterogeneous murine leukemia virus-infected cell population. (1984) (2)
- A new polymorphic probe on chromosome 3p: lambda LIB31-38 (D3S726). (1991) (2)
- A new polymorphic probe on chromosome 3p: lambda LIB19-63' (D3S601). (1991) (2)
- A new polymorphic probe on chromosome 3p: λLIB13–67 (D3S591) (1991) (2)
- A new polymorphic probe on chromosome 3p:lambda LIB29-48(D3S624). (1990) (2)
- Serotherapy of cancer: Cellular changes in primary rat mammary carcinomas after infusion of syngeneic sera absorbed with protein a‐sepharose (1988) (2)
- OVERVIEW OF VON HIPPEL-LINDAU DISEASE (1999) (2)
- Specific and Nonspecific Immunotherapy: Use of BCG (1974) (2)
- A new polymorphic probe on chromosome 3p: ?LIB32-90' (D3S216) (1990) (2)
- A new polymorphic probe on chromosome 3p: λLIB36-68 (D3S615) (1991) (2)
- A new polymorphic probe on chromosome 3p: λLIB27–98″ (D3S1096) (1991) (1)
- Pulmonary metastases in guinea pigs as a consequence of dermal implantation of line-10 tumor cells (1981) (1)
- A new polymorphic probe on chromosome 3p: λLIB43–55′ (D3S728) (1991) (1)
- Re: Hereditary Papillary Renal Cell Carcinoma; Re (1996) (1)
- A new polymorphic probe on chromosome 3p: λLIB37 – 97" (D3S724) (1991) (1)
- A new polymorphic probe on chromosome 3p: λLIB18–88″ (D3S1093) (1991) (1)
- Molecular Studies of the VHL Tumor Suppressor Gene in Renal Cell Carcinoma (1995) (1)
- Mutations in fumarate hydratase cause hereditary leiomyomatosis and renal cell carcinoma in families in North America 1 1 Disclosure not available at press time. (2004) (1)
- The biology and genetics of hereditary cancers. (1992) (1)
- A new polymorphic probe on chromosome 3p: λLIB15–44 (D3S596) (1991) (1)
- A new polymorphic probe on chromosome 3p: λLIB39-63 (D3S616) (1991) (1)
- A new polymorphic probe on chromosome 3p:λLIB29-48(D3S624) (1991) (1)
- Chromosomal imbalances in sporadic and hereditary papillary renal cell carcinomas by comparative genomic hybridization (CGH) (1997) (1)
- A new polymorphic probe on chromosome 3p: lambda LIB46-100 (D3S641). (1991) (1)
- A dinucleotide repeat polymorphism in the gene for the γ subunit of the human Fcε receptors (FLER16) (1993) (1)
- Structural basis of oncogenesis caused by point mutations in the kinase domain of the MET proto-oncogene (1998) (1)
- A new polymorphic probe on chromosome 3p: lambda LIB17-11 (D3S1092). (1991) (1)
- A new polymorphic probe on chromosome 3p: λLIB41 – 51 (D3S632) (1991) (1)
- Genetic susceptibility to renal cell carcinoma (2003) (1)
- ErratumFocus on kidney cancer (2004) (1)
- Germline Mutations in the n Hippel-Lindau Disease (VrwL) Gene in Families From America, Europe, and Japan (1996) (1)
- Molecular Analysis of DNA Sequences on Chromosome 3 in Patients with Renal Cell Carcinoma (1992) (1)
- Deletion of chromosome 3p in three tumor types associated with Von Hippel-Lindau Disease (VHL) (1989) (1)
- A new polymorphic probe on chromosome 3p: ?LIB45-82 (D3S232) (1990) (1)
- A MspI polymorphism and linkage mapping of the human protein-tyrosine phosphatase G (PTPRG) gene. (1993) (1)
- Molecular and genetic characterization and physical mapping of 11 new markers detecting multiallele restriction fragment length polymorphisms on the short arm of human chromosome 3 (1992) (1)
- A new polymorphic probe on chromosome 3p: λLIB24–12′ (D3S727) (1991) (1)
- 1398: Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC): An Aggressive form of Inherited Renal Cancer (2005) (1)
- A specific germline mutation in the VHL tumor suppressor gene correlates with pheochromocytoma (1995) (1)
- Genotype-phenotype correlations in von Hippel-Lindau disease (VHL) (1994) (1)
- 585 HEREDITARY PAPILLARY RENAL CELL CARCINOMA: A 20-YEAR EXPERIENCE IN MANAGEMENT OF A UNIQUE HEREDITARY CANCER SYNDROME (2012) (1)
- A new polymorphic probe on chromosome 3p:λLIB46-95(D3S620) (1991) (1)
- A new polymorphic probe on chromosome 3p: λLIB05–24 (D3S623) (1991) (1)
- A new polymorphic probe on chromosome 3p: λLIB19–63′ (D3S601) (1991) (1)
- Onkogenic activation caused by poitn mutations in the kinase domain of the met proto-oncogene: molecular modeling studies (2001) (1)
- A new polymorphic probe on chromosome 3p: λLIB4–59 (D3S575) (1991) (1)
- In vivo immunologic selection of class I major histocompatibility complex gene deletion variants from the B16-BL6 melanoma. (1987) (1)
- Resistance to tumor growth in guinea pigs immunized with lyophilized tumor cells (1977) (1)
- A new polymorphic probe on chromosome 3p: ?LIB31-57' (D3S213) (1990) (1)
- Sporadic clear cell papillary cystadenoma of the epididymis can show somatic mutation of the VHL gene (1996) (1)
- 343 Novel role of fumarate in antagonizing VHL function (2004) (1)
- A new polymorphic probe on chromosome 3p: λLIB03–23 (D3S573) (1991) (0)
- Host-clonal interactions in the generation of proviral gene deletion variants. (1987) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB37-96' (D3S1192). (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB11-95(D3S730). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB27-98" (D3S1096). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB27-77 (D3S603). (1991) (0)
- A new DNA marker, D3S733, identifies a HindIII polymorphism on chromosome 3p. (1991) (0)
- Abstract 2198: Exome and transcriptome sequencing of human tumors and tumor-derived cell lines (2010) (0)
- A new polymorphic probe on chromosome 3p:λLIB25-55(D3S602) (1991) (0)
- A new DNA marker, D3S743, identifies a MspI polymorphism on chromosome 3p. (1991) (0)
- A dinucleotide repeat polymorphism in the gene for the gamma subunit of the human Fc epsilon receptors (FLER16). (1993) (0)
- Efficacy of mycobacterial components in the immunotherapy of mice with pulmonary tumor deposits (1981) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB46-35'(D3S636). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB43-55' (D3S728). (1991) (0)
- A nex polymorphic probe on chromosome 3p:λLIP17-58(D3S598) (1991) (0)
- A new DNA marker, D3S740, identifies a MspI polymorphism on chromosome 3p. (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB31-57' (D3S213). (1990) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB45-82 (D3S232). (1990) (0)
- A microsatellite polymorphic probe on chromosome 3p: lambda LIB12-2CATT (D3S1244). (1992) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB25-55(D3S602). (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB41-10(D3S618). (1991) (0)
- A new polymorphic probe on chromosome 3p: LIB46-35'(D3S636) (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB38-85 (D3S625). (1991) (0)
- A new polymorphic probe on chromosome 3p:λLIB35-53(D3S731) (1991) (0)
- Mitotic arrest and cellular senescence by the acute inactivation of the VHL gene (2005) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB49-63 (D3S192E). (1990) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB39-63 (D3S616). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB36-68 (D3S615). (1991) (0)
- Von Hippel-Lindau Syndrome : Cloning and Identification of the Plasma Membrane Ca + +-transporting ATPase Isoform 2 Gene That Resides in the Von Hippel-Lindau Gene Region 1 (2006) (0)
- A new polymorphic probe on chromosome 3p:λLIB11-95(D3S730) (1991) (0)
- Re: Junya Toguchida et al., Assignment of Common Allele Loss in Osteosarcoma to Subregion 17p13. Cancer Res., 49: 6247-6251, 1989. (1990) (0)
- Role of ecotropic murine leukemia virus (mulv) in the immunoprophylaxis of a syngeneic methylcholanthrene- -induced murine fibrosarcoma. Abstr. (1980) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB4A-52''(D3S732). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB24-12' (D3S727). (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB30-62'(D3S606). (1991) (0)
- Cover, Volume 42, Issue 5 (2021) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB05-24 (D3S623). (1991) (0)
- IL-14 Genetic alterations of human renal cell carcinomas (2004) (0)
- A new polymorphic probe on chromosome 3p: λLIB13–49′ (D3S723) (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB09-75' (D3S584). (1991) (0)
- A new polymorphic probe on chromosome 3p: λLIB38–85 (D3S625) (1991) (0)
- VHL Disease with Pheochromocytoma in the Black Forest Is Caused by a TℲC Change at Nucleotide 505 (Tyr98His) of the VHL Gene Which Was Introduced by a Common Ancestor (1996) (0)
- Annual Trainee Award for 1999 (2017) (0)
- Title Von Hippel-Lindau ( VHL ) disease : distinct phenotypes suggest more than one mutant allele at the VHL locus Permalink (2004) (0)
- WsomY 7-Harbouring Non-Random Duplication of the Mutant MET Allele in Hereditary Pap- (1998) (0)
- GENOTYPE‐PHENOTYPE ASSOCIATIONS IN VON HIPPEL‐LINDAU: PD46‐07 (2018) (0)
- Meeting Report Third International Meeting on von Hippel-Lindau Disease 1 (2000) (0)
- A centromeric microsatellite probe on chromosome 3: LIB 9-95ca (D3S1338). (1993) (0)
- Immunoprophylaxisof SyngeneicMethyicholanthrene-inducedMurine Sarcomaswith BacillusCalmette-Guérin and Tumor Cells (2006) (0)
- Presymptomatic diagnosis ofvon Hippel-Lindau disease withflanking DNA markers (1992) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB45-86 (D3S633). (1991) (0)
- From Immunotherapy of Cancer to the Discovery of Kidney Cancer Genes: A Personal History (2013) (0)
- A new DNA marker, D3S742, identifies a MspI and a TaqI polymorphism on chromosome 3p. (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB28-56'' (D3S207). (1990) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB34-60 [D3S154]. (1989) (0)
- A new polymorphic probe on chromosome 3p;λLIB28-32(D3S736) (1991) (0)
- Rigaud and Schmincke Types of Lymphoepithelioma (2011) (0)
- Immunotherapy with BCG: approaches to human malignant melanoma based on a guinea pig model (1975) (0)
- Birt-Hogg-Dubé syndrome: identification of a novel gene and its clinical manifestations1 (2004) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB4-59 (D3S575). (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB35-53(D3S731). (1991) (0)
- Advances in Brief Somatic Mutations in the Kinase Domain of the Met / Hepatocyte Growth Factor Receptor Gene in Childhood Hepatocellular Carcinomas 1 (1999) (0)
- A new DNA marker, D3S640, Identifies a Dral, Hindlll polymorphisms on chromosome 3p (1991) (0)
- A new polymorphic probe on chromosome 3p: λLIB45–86 (D3S633) (1991) (0)
- Isolation of candidate tumor suppressor genes for small cell lung cancer (SCLC) from human chromosome 3p21.3 (1994) (0)
- Tumor growth induced by MET mutant M1268T in papillary renal carcinoma is dependent on c-Src activity (2000) (0)
- MAPPING OF GERMLINE DELETIONS OF THE VON HIPPEL-LINDAU TUMOR SUPPRESSOR GENE (1999) (0)
- Adenovirus type-7 T antigen: separation from hexon antigen by gel filtration. A preliminary report. (1968) (0)
- COMMENTARIES ON: HEREDITARY PAPILLARY RENAL CELL CARCINOMA BY B. ZBAR ET AL. (1996) (0)
- A new polymorphic probe on chromosome 3p: λLIB50–50′ (D3S1099) (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB28-62(D3S736). (1991) (0)
- Germline mutations in the von Hippel-Lindau tumor suppressor gene and preclinical diagnosis of gene carriers (1994) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB18-88 (D3S1093). (1991) (0)
- A new polymorphic probe on chromosome 3p:λLIB30-62′(D3S606) (1991) (0)
- Gene Von Hippel-Lindau (VHL) and corresponding cDNA and methods for detecting gene carriers of VHL disease. (1994) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB32-90' (D3S216). (1990) (0)
- A new polymorphic probe on chromosome 3p: ?LIB34-60 [D3S154] (1989) (0)
- A NEX POLYMORPHIC PROBE ON CHROMOSOME 3P:LAMBDA LIP17-58(D3S598) (1991) (0)
- A new polymorphic probe on chromosome 3p: LIB29-48(D3S624) (1991) (0)
- A new polymorphic probe on chromosome 3p:λLIB45-35'(D3S636) (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB08-60'' (D3S729). (1991) (0)
- A new polymorphic probe on chromosome 3p:λLIB49Λ63 S192E) (1990) (0)
- A polymorphic dinucleotide repeat probe on chromosome 3p: LIB 44-36ca (D3S769). (1993) (0)
- PREVALENCE OF MICROSCOPIC TUMORS IN NORMAL RENAL PARENCHYMA FROM PATIENTS WITH RENAL CANCER ASSOCIATED WITH HEREDITARY PAPILLARY RENAL CANCER SYNDROME: CLINICAL AND GENETIC IMPLICATIONS (1999) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB13-49' (D3S723). (1991) (0)
- A new polymorphic probe on chromosome 3p: λLIB08–60‴ (D3S729) (1991) (0)
- Immunoprophylaxis of SyngeneicMethyicholanthrene-induced Murine Sarcomaswith BacillusCalmette-Guérin andTumorCells (1980) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB37-97'' (D3S724). (1991) (0)
- Fourteen new polymorphic dinucleotide repeats on human chromosome 3: D3S1432, D3S1433, D3S1434, D3S1483, D3S1484, D3S1485, D3S1486, D3S1487, D3S1488, D3S1489, D3S1490, D3S1496, D3S1497 and D3S1498. (1994) (0)
- Molecular and Cellular Characterization of Human Renal Cell Carcinoma Cell (2006) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB50-50' (D3S1099). (1991) (0)
- A new polymorphic probe on chromosome 3p: λLIB28-56″ (D3S207) (1990) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB38-96 (D3S191). (1990) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB46-27' (D3S635). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB13-67 (D3S591). (1991) (0)
- BCG and cancer. (1981) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB03-23 (D3S573). (1991) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB46-95(D3S620). (1991) (0)
- Immunogenicity and immunosensitivity of a guinea pig B-cell leukemia subline lacking cell surface Ia antigens. (1985) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB15-44 (D3S596). (1991) (0)
- S13-4 Frontiers in renal cell carcinoma research (2004) (0)
- A new polymorphic probe on chromosome 3p:lambda LIB17-58(D3S598). (1991) (0)
- A new DNA marker, D3S754, identifies a HindIII polymorphism on chromosome 3p. (1991) (0)
- Gene VHL Inactivation of the Impaired Spermatogenesis in Mice with Conditional Hepatic Vascular Tumors , Angiectasis in Multiple Organs , and Updated (2003) (0)
- Detection ofgermline mutations inthevon Hippel-Lindau disease genebytheprimer specified restriction mapmodification method (1995) (0)
- A new polymorphic probe on chromosome 3p:?LIB4A-52?(D3S732) (1991) (0)
- PROCEEDINGS, XI INTERNATIONAL CANCER CONGRESS, FLORENCE 1974 (1975) (0)
- A NEW POLYMORPHIC PROBE ON CHROMOSOME 3P:LAMBDA LIB45-35'(D3S636) (1991) (0)
- Immunoprophylaxis of syngeneic methycholanthrene-induced murine sarcomas with Bacillus Calmette-Guérin and tumor cells. (1980) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB41-51 (D3S632). (1991) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB49-60 [D3S155]. (1989) (0)
- A new polymorphic probe on chromosome 3p: lambda LIB33-29' (D3S629). (1991) (0)
- Immunoprophylaxis of syngeneic murine sarcomas with BCG and tumor cells: Optimization of conditions (1979) (0)
- A new DNA marker, D3S640, identifies a DraI, HindIII and TaqI polymorphisms on chromosome 3p. (1991) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Berton Zbar?
Berton Zbar is affiliated with the following schools:
